Ligand Pharmaceuticals Incorpor (LGND) Financials
LGND Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 833.1 million | 130.7 million |
2023-09-30 | 769.2 million | 103.8 million |
2023-06-30 | 758.1 million | 93.2 million |
2023-03-31 | 811.1 million | 164.8 million |
LGND Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -42.7 million | 5.7 million |
2023-09-30 | 7.2 million | 6.9 million |
2023-06-30 | -285000 | 7.2 million |
2023-03-31 | 31.5 million | 5.9 million |
LGND Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | 18.2 million |
2023-09-30 | -10.3 million |
2023-06-30 | 2.3 million |
2023-03-31 | 41.9 million |
LGND Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 170.3 million | - | 6.2 million |
2023-09-30 | 190.5 million | - | 6.3 million |
2023-06-30 | 219.0 million | - | 11.7 million |
2023-03-31 | 282.7 million | - | 11.9 million |
LGND Shares Outstanding
LGND Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 50.7 million | 5.5 million | 16.0 million | - |
2023-09-30 | 487000 | 5.5 million | 14.7 million | - |
2023-06-30 | 203000 | 6.9 million | 11.3 million | - |
2023-03-31 | 2.4 million | 6.7 million | 10.9 million | - |
LGND Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 28.1 million | 1.7 million |
2023-09-30 | 32.9 million | 3.5 million |
2023-06-30 | 26.4 million | 1.7 million |
2023-03-31 | 44.0 million | 3.7 million |
LGND
Price: $73.90
52 week price:
Earnings Per Share: 3.03 USD
P/E Ratio: 65.36
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 186100
Ebitda: 19.2 millionMarket Capitalization: 1.4 billion